1,8-Dihydroxyhexadecan | 39516-52-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 1,8-Dihydroxyhexadecan
• 英文别名: Hexadecane-1,8-diol
• CAS: 39516-52-4
• 化学式: C₁₆H₃₄O₂
• 分子量: 258.445
• InChiKey: VPNYRZXERIVYEI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.2
• 重原子数：
  18
• 可旋转键数：
  14
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• IONIZABLE CATIONIC LIPID FOR RNA DELIVERY
  申请人：Arcturus Therapeutics, Inc.

  公开号：US20180169268A1

  公开（公告）日：2018-06-21

  What is described is a compound of formula I consisting of a compound in which R 1 is a branched chain alkyl consisting of 10 to 31 carbons; R 2 is a linear alkyl, alkenyl, or alkynyl consisting of 2 to 20 carbons; L 1 and L 2 are the same or different, each a linear alkylene of 1 to 20 carbons or a linear alkenylene of 2 to 20 carbons; X 1 is S or O; R 3 is a linear or branched alkylene consisting of 1 to 6 carbons; and R 4 and R 5 are the same or different, each a hydrogen or a linear or branched alkyl consisting of 1 to 6 carbons; or a pharmaceutically acceptable salt thereof.

  描述的是一种化合物，其化学式为I，包括以下成分： R1为由10至31个碳组成的支链烷基化合物； R2为由2至20个碳组成的直链烷基、烯基或炔基； L1和L2相同或不同，每个为由1至20个碳组成的直链烷基或由2至20个碳组成的直链烯基； X1为S或O； R3为由1至6个碳组成的直链或支链烷基； R4和R5相同或不同，每个为氢或由1至6个碳组成的直链或支链烷基；或其药用可接受盐。
• Ionizable cationic lipid for RNA delivery
  申请人：Arcturus Therapeutics, Inc.

  公开号：US10383952B2

  公开（公告）日：2019-08-20

  What is described is a compound of formula I consisting of a compound in which R1 is a branched chain alkyl consisting of 10 to 31 carbons; R2 is a linear alkyl, alkenyl, or alkynyl consisting of 2 to 20 carbons; L1 and L2 are the same or different, each a linear alkylene of 1 to 20 carbons or a linear alkenylene of 2 to 20 carbons; X1 is S or O; R3 is a linear or branched alkylene consisting of 1 to 6 carbons; and R4 and R5 are the same or different, each a hydrogen or a linear or branched alkyl consisting of 1 to 6 carbons; or a pharmaceutically acceptable salt thereof.

  所述的是式 I 的化合物 其中 R1 是由 10 至 31 个碳原子组成的支链烷基；R2 是由 2 至 20 个碳原子组成的直链烷基、烯基或炔基；L1 和 L2 相同或不同，各自是 1 至 20 个碳原子的直链亚烷基或 2 至 20 个碳原子的直链烯基；X1 是 S 或 O；R3 是由 1 至 6 个碳原子组成的直链或支链亚烷基；R4 和 R5 相同或不同，各自是氢或由 1 至 6 个碳原子组成的直链或支链烷基；或其药学上可接受的盐。
• ALKYL DIOLS FOR CRUDE OIL TREATMENT
  申请人：Ecolab USA Inc.

  公开号：US20170233666A1

  公开（公告）日：2017-08-17

  The present invention generally relates to methods and compounds for reducing paraffin or wax deposition in crude oil during processing, storage, or transportation. More specifically, the method comprises contacting the crude oil with a composition in an amount effective to reduce paraffin or was deposition.
• [EN] IONIZABLE CATIONIC LIPID FOR RNA DELIVERY<br/>[FR] LIPIDE CATIONIQUE IONISABLE DESTINÉ À L'ABSORPTION D'ARN
  申请人：ARCTURUS THERAPEUTICS INC

  公开号：WO2018118102A1

  公开（公告）日：2018-06-28

  What is described is a compound of formula (I) consisting of a compound in which R1 is a branched chain alkyl consisting of 10 to 31 carbons; R2 is a linear alkyl, alkenyl, or alkynyl consisting of 2 to 20 carbons; L1 and L2 are the same or different, each a linear alkylene of 1 to 20 carbons or a linear alkenylene of 2 to 20 carbons; X1 is S or O; R3 is a linear or branched alkylene consisting of 1 to 6 carbons; and R4 and R5 are the same or different, each a hydrogen or a linear or branched alkyl consisting of 1 to 6 carbons; or a pharmaceutically acceptable salt thereof.
• [EN] IONIZABLE CATIONIC LIPID FOR RNA DELIVERY<br/>[FR] LIPIDE CATIONIQUE IONISABLE POUR L'ADMINISTRATION D'ARN
  申请人：PAYNE JOSEPH E

  公开号：WO2018119163A1

  公开（公告）日：2018-06-28

  What is described is a compound of formula (I) consisting of a compound in which R1 is a branched chain alkyl consisting of 10 to 31 carbons; R2 is a linear alkyl, alkenyl, or alkynyl consisting of 2 to 20 carbons, or a branched chain alkyl consisting of 10 to 31 carbons; L1 and L2 are the same or different, each a linear alkane of 1 to 20 carbons or a linear alkene of 2 to 20 carbons; X1 is S or O; R3 is a linear or branched alkylene consisting of 1 to 6 carbons; and R4 and R5 are the same or different, each a hydrogen or a linear or branched alkyl consisting of 1 to 6 carbons; or a pharmaceutically acceptable salt thereof.